SCOR SE (SDRB) AI Stock Analysis

1 Followers

SCOR SE

(Frankfurt:SDRB)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

P&C Underwriting QualityA low combined ratio indicates that SCOR is currently converting premiums into underwriting profit with meaningful efficiency. Continued reserve strengthening and disciplined risk selection can improve resilience, support capital generation, and help preserve profitability through changing reinsurance conditions.

Negative Factors

P&C Pricing PressurePersistent competition and falling catastrophe prices can compress future underwriting margins even when loss experience remains favorable. SCOR’s emphasis on margin over volume helps mitigate the risk, but renewal pressure could still reduce the profitability of newly written business.

SCOR SE (SDRB) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 74.15B
Dividend Yield: 5.18%
Average Volume (3M): 570
Price to Earnings (P/E): 7.9
Beta (1Y): 0.55
Revenue Growth: -4.01%
EPS Growth: -7.21%
Country: Germany
Employees: 3,610
Sector: Financial
Sector Strength: 68
Industry: Insurance - Reinsurance

SCOR SE Business Overview & Revenue Model

Company Description

SCOR SE functions as a prominent global reinsurance provider, offering a comprehensive suite of life and non-life protection solutions. The company boasts a broad international footprint, serving clients across Europe, the Middle East, Africa, the Am...

SCOR SE Earnings Call Summary

Earnings Call Date:Oct 30, 2026(Q3-2026)|% Change Since:8.92%|Next Earnings Date:Mar 10, 2027

Earnings Call SentimentPositive

The call was strongly positive overall. SCOR reported robust profitability, capital strength, economic value growth above target, strong P&C underwriting performance, consistent Life & Health results, and positive investment income. Management acknowledged meaningful challenges from P&C market softening, pricing pressure, catastrophe and other losses, EGPI revisions, and selected business exits, but described these risks as understood and incorporated into its plans. The highlights significantly outweighed the lowlights.

Positive Updates

Strong Nine-Month Net Income and Return on Equity

Group net income reached EUR 615 million in the first 9 months, corresponding to an annualized return on equity of 19.3%, despite increased competition in P&C, a negative one-off arbitration impact in Life & Health in the second quarter, and continued buffer building in P&C.

Negative Updates

Continued P&C Market Softening and Competition

Management said competition remains high and the P&C market is softening. The company expects further softening to be reflected in its new strategic plan and does not assume a blue-sky scenario.

Company Guidance

SCOR expects competition to remain high at the 1st of January 2027 renewals, with margin and quality over volume, and expects price decreases in cat of high single digit, low double digit; the outlook for '27 is something in line with what we saw in '26 so far. Management estimates the deterioration between '25 and '26 to be limited to approximately 2 points of combined ratio, expects to continue to build buffers, and said the cat exposure does not change the 10% guidance. SBS is expected to show some growth and continue to be a good driver of revenue growth, while SCOR expects to reach its objective of neutral or positive cash flow on the Life & Health side in 2026; the Solvency II review guidance remains 10% to 15%, and the Forward 2026 targets include 12% ROE and 9% annual growth.

SCOR SE Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

DE:SDRB against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPNT	80Outperform	$3.06B	6.39	21.64%	―	18.14%	163.19%
AXS	78Outperform	$7.80B	7.27	17.80%	1.62%	10.16%	7.89%
RGA	78Outperform	$17.90B	10.52	13.15%	1.37%	22.58%	99.93%
RNR	76Outperform	$14.29B	10.06	13.52%	0.46%	-21.18%	-3.27%
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
EG	65Neutral	$15.82B	9.09	12.52%	1.87%	-8.72%	250.85%

* Financial Sector Average

Performance Comparison

DE:SDRB and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:SDRB	SCOR SE (ADR)	3.42	0.89	35.28%
AXS	Axis Capital Holdings	108.72	9.72	9.82%
EG	Everest Group, Ltd.	427.19	114.46	36.60%
RGA	Reinsurance Group Of America	275.15	93.35	51.35%
RNR	Renaissancere	353.62	92.30	35.32%
SPNT	Siriuspoint Ltd	26.57	6.84	34.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

SCOR SE AI Stock Analysis